NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT03879629 2025-11-20
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
Mayo Clinic
Phase 2 Active not recruiting
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT02717507 2025-04-23
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Children's Oncology Group
Phase 2 Completed